期刊文献+

转化生长因子-β1基因修饰神经干细胞在大鼠脑缺血模型中的试验研究 被引量:1

Experimental study on treatment of cerebral ischemic-reperfusion injury with TGF-β1-transfected neural stem cells transplantation in rats
原文传递
导出
摘要 目的通过向大鼠脑缺血损伤区的靶向移植转化生长因子-β1(TGF-β1)基因修饰的神经干细胞,观察TGF-β1基因修饰的神经干细胞对大鼠脑缺血损伤的治疗作用。方法建立大鼠的局灶性脑缺血再灌注模型,并随机分为假手术组(A组)、磷酸盐缓冲液PBS组(B组)、神经干细胞治疗组(C组)、TGF-β1基因修饰神经干细胞组(D组),根据取样时间点的不同每组又分为3、7及14 d共三组(每组5只),手术后3、7、14 d进行神经功能评分(NSS),采用5-溴-2,-脱氧尿嘧啶核苷(BrdU)标记处于增殖状态的细胞,应用免疫组化法检测BrdU阳性细胞。结果术后3、7、14 d C组和D组NSS评分明显低于A组和B组,统计学分析差异有统计学意义(P<0.05),其中D组NSS评分较C组低,两组比较差异有统计学意义(P<0.05);C组和D组大鼠在脑缺血/再灌注后3、7、14 d均可检测到BrdU阳性细胞,BrdU阳性细胞计数显示各个时间点C组和D组阳性细胞数明显多于对照组(P<0.05)。结论在局灶性脑缺血再灌注模型大鼠损伤区注入TGF-β1基因修饰的神经干细胞,对脑缺血所致的损伤具有一定的修复作用。 Objective To investigate the effect of transforming growth factor - β1 ( TGF - β1 ) - transfected neural stem cells on focal cerebral ischemia -reperfusion in rat. Methods Temporary middle cerebral artery occlusion models were established and randomly divided into sham - operated group ( A group), phosphate buffer saline group ( B group), neural stem cell group( C group), TGF - β1 - transfectecl neural stem cell group( D group). Above four groups again divided into 3 d、7 d and 14 d group according the different times. The neurological severity scores(NSS) were evaluated in different times. 5 -Bromo -2, -cleoxyuridine (BrdU) was applied to labeling cell proliferation, immunohistoehemistry was used to detect positive cells of BrdU. Results The NSS in C group and D group were lower than A group and B group after 3 d 、7 d and 14 d ( P 〈 0.05 ). And the NSS in D group was lower than C group after 3 d,7 d and 14 d (P 〈0.05). C group and D group all detected positive cells of BrdU. Positive cells of BrdU were situated in the ipsilateral cortex near the infarct boundary,subventricular area and around blood vessels in the ipsilateral cortex. The positive cells of BrdU in C group and D group were more than A group and B group ( P 〈 0. 05 ). Conclusion TGF - β1 - transfeeted neural stem cells may reduce neural damage after transplanted into the focal cerebral ischemia- reperfusion in rats.
出处 《临床医学》 CAS 2008年第5期105-107,共3页 Clinical Medicine
基金 深圳市科技计划项目(JH200505310604A)
关键词 转化生长因子-Β1 神经干细胞 脑缺血/再灌注损伤 Transforming growth factor -β1 Neural stem cell Cerebral ischemia - reperfusion
  • 相关文献

参考文献9

  • 1Mondal D,Pradhan L,Larussa VF.Signal traneduction pathways involved in the lineage-differentiation of NSCs:can the knowledge gained from blood be usedinthe brain?[J].Cancer Invest,2004,22(6):925-943.
  • 2Zhang JQ,Yu XB,Ma BF,et al.Neural differentiation of embryonic stem cens induced by conditioneyl medium from neural stem cell[J].Neuroreport,2006,17(10):981-986.
  • 3Mishra L,Marshall B.Adaptor proteins and ubiquinators in TGFbeta signaling[J].Cytokine Growth Factor Rev.2006,17(1-2):75-87.
  • 4Golestaneh N,Mishra B.TGF-beta,neuronal stem cells and gliobIatoma[J].Oncogene,2005,24(37):5 722-5 730.
  • 5Krupinski J,Kumar P,Kumar S,et al.Increased expression of TGF-beta 1 in brain tissue after ischemie stroke in humans[J].Stroke.1996,27(5):852-857.
  • 6Zhu Y,Yang GY,Ahlemeyer B,et al.Transforming growth factorbeta 1 increases bad phosphorylation and protects neurons against damage[J].J Neurosci,2002,22(10):3 898.
  • 7Kitamura S,Maeshima Y,Sugnya T.Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells[J].Nephron Exp Nephrol,2003,95(2):79-86.
  • 8Kitagawa H,Abe K,Hayashi T,et al.Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats[J].Neural Res,1998,20(4):333-336.
  • 9Battista D,Ferrari CC,Gage FH,et al.Neurogenie niche modulation by activated microglia:transforming growth factor beta increases neurogenesis in the adult dentate gyrus[J].Ear J Neurosci,2006,23(1):83-93.

同被引文献14

  • 1李少一,高芸,刁宏宇,王成林,难波宏树.应用导入HSVtk基因的神经干细胞治疗胶质瘤的体外实验研究[J].中华神经外科杂志,2006,22(12):759-761. 被引量:4
  • 2姬西团,章翔,刘卫平,费舟,张剑宁,蒋晓帆,宋少军,宋蕾,梁景文.小鼠神经干细胞对胶质瘤趋向性实验研究[J].中华神经外科疾病研究杂志,2007,6(3):196-198. 被引量:3
  • 3Gage HF. Mammalian neural stem cell. Science ,2000,287 :1433-1438.
  • 4Diber MS, Phelan A, Mohamed A J, et al. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplx virus protein VP22. Gene Therapy, 1999,6 : 12-21.
  • 5Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA,2000,97:12846-12851.
  • 6Ehtesham M, Kabos P, Gutierrez MA, et al. Induction of gliob-1 astoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res, 2002,62 : 7170 -7174.
  • 7Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using nerual progenitor cells. Nat Med,2000,6:447-450.
  • 8Colleoni F, Torrente Y. The new challenge of stem cell: brain tumour therapy. Cancer Letters ,2008,272 : 1-11.
  • 9Nestler U, Keinkelein M, Lueke M, et al. Roamy virus vectors for suicide gene therapy. Gene Ther, 1997,4 : 1270-1277.
  • 10Zavaglia D, Favrot MC, Eymin B, et al. Intercellular trafficking and enhanced in vivo antitumor activity of a non-virally delivered p27-VP22 fusion protein. Gene Ther,2003,10:314-325.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部